Analyst Research
| Report Title | Price |
|---|---|
|
Trading Report for (ABT). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
|
$58.00
|
|
Provider: S&P Capital IQ Quantitative Report
|
$35.00
|
|
Provider: Plunkett Research, Ltd.
|
$99.00
|
|
Provider: Plunkett Research, Ltd.
|
$99.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Abbott Laboratories Declares Quarterly Dividend
Abbott Laboratories declared its quarterly cash dividend. The quarterly dividend is $0.14 per share, payable February 15, 2013, to shareholders of record on January 15, 2013. The management of AbbVie, Abbott's research-based pharmaceuticals business, intends to recommend a cash dividend, subject to AbbVie board approval, of $0.40 per share, which together with Abbott's dividend will equal a cash dividend of $0.54 per share, an increase of nearly 6% over Abbott's quarterly cash dividend declared in September 2012.
Latest Developments for Abbott Laboratories
- Abbott Laboratories Announces CE Mark For Coronary Drug Eluting Stent
- Russia Rejects Abbott Laboratories Plan To Buy Petrovax-Reuters
- Abbott Laboratories Announces FDA Approval And U.S. Launch Of TECNIS Toric Intraocular Lens For Cataract Patients
- Abbott Laboratories Issues Q2 2013 EPS Guidance In Line With Analysts' Estimates; Reaffirms FY 2013 EPS Guidance
Latest Key Developments in Pharmaceuticals
- Share this
- Link this
- Digg this
Follow Reuters